Alendronic acid/colecalciferol explained

Type:combo
Component1:Alendronic acid
Class1:Bisphosphonate
Component2:Colecalciferol
Class2:Vitamin
Tradename:Fosamax Plus D, Fosavance, Adrovance, others
Dailymedid:Fosamax Plus D
Pregnancy Au:B3
Routes Of Administration:By mouth
Atc Prefix:M05
Atc Suffix:BB03
Legal Ca:Rx-only
Legal Ca Comment:[1]
Legal Uk:POM
Legal Uk Comment:[2]
Legal Us:Rx-only
Legal Eu:Rx-only
Legal Status:Rx-only
Cas Number:1215291-18-1
Kegg:D10841

Alendronic acid/colecalciferol, sold under the brand name Fosamax Plus D among others, is a medication for the treatment of osteoporosis in men or in postmenopausal women.[3] [4] [5]

Alendronic acid/colecalciferol was approved for use in the United States and in the European Union in 2005.[6] [7]

Notes and References

  1. Web site: Product monograph brand safety updates . . 7 July 2016 . 3 April 2024 . 29 March 2024 . https://web.archive.org/web/20240329200203/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database/label-safety-assessment-update/product-monograph-brand-safety-updates.html . live .
  2. Web site: Fosavance Tablets - Summary of Product Characteristics (SmPC) . (emc) . 1 March 2020 . 2 March 2020 . https://web.archive.org/web/20200302055611/https://www.medicines.org.uk/emc/product/110/smpc . live .
  3. Web site: Fosamax Plus D- alendronate sodium and cholecalciferol tablet . DailyMed . 16 August 2019 . 1 March 2020 . 19 December 2019 . https://web.archive.org/web/20191219012915/https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c0ec7e75-03b9-4b5b-ca8b-58cb0f65b5d9 . live .
  4. Web site: Adrovance EPAR . European Medicines Agency (EMA) . 26 February 2020 . 1 March 2020 . 2 March 2020 . https://web.archive.org/web/20200302055641/https://www.ema.europa.eu/en/medicines/human/EPAR/adrovance . live .
  5. Von Schacht E, Dambacher MA, Ringe JD, Dukas L . [Combination of alendronate plus alfacalcidol in the treatment of osteoporosis. Rationale, preclinical data and clinical evidence] . German . MMW Fortschritte der Medizin . 154 . Suppl 1 . 10–21 . April 2012 . 23427364 .
  6. Web site: Drug Approval Package: Fosamax Plus D (Alendronate Sodium) NDA #021762 . U.S. Food and Drug Administration (FDA) . 8 June 2006 . 1 March 2020 . 2 March 2020 . https://web.archive.org/web/20200302055610/https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021762s000_FosamaxTOC.cfm . live .
  7. Web site: Fosavance EPAR . European Medicines Agency (EMA) . 9 October 2019 . 1 March 2020 . 2 March 2020 . https://web.archive.org/web/20200302055609/https://www.ema.europa.eu/en/medicines/human/EPAR/fosavance . live .